Both 5-hydroxytryptamine 5-HT2A and 5-HT1B receptors are involved in the vasoconstrictor response to 5-HT in the human isolated internal thoracic artery

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 7, 2008, Pages 836-840

  Tanaka, Naoko ^a   Nakamura, Eisaku ^b   Ohkura, Masamichi ^a,d   Kuwabara, Masachika ^b,e   Yamashita, Atsushi ^c   Onitsuka, Toshio ^c   Asada, Yujiro ^c   Hisa, Hiroaki ^a   Yamamoto, Ryuichi ^a  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b Nobeoka Prefectural Hospital   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e Kuwabara Clinic   (Japan)

Author keywords

5 HT1B and 5 HT2A receptors; Human internal thoracic artery; Sarpogrelate; SB224289; Vasoconstriction

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; SARPOGRELATE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR;

ANTIBODY LABELING; ARTERY GRAFT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAMMARY ARTERY; VASOCONSTRICTION; VASOSPASM;

HUMANS; MAMMARY ARTERIES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; VASOCONSTRICTION;

EID: 44249097091     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04933.x     Document Type: Article

References (36)

1. Green GE, Stertzer SH, Reppert EH. Coronary arterial bypass grafts. Ann. Thorac. Surg. 1968 5 : 443 50.
2. Okies JE, Page US, Bigelow JC, Krause AH, Salomon NW. The left internal mammary artery: The graft of choice. Circulation 1984 70 (Suppl. 1 213 21.
3. Loop FD, Lytle BW, Cosgrove DM et al. Influence of internal-mammary- artery graft on 10 years survival and other cardiac events. N. Engl. J. Med. 1986 314 : 1 6.
4. Mills NL, Bringaze WL. Preparation of the internal mammary artery graft. Which is the best method? J. Thorac. Cardiovasc. Surg. 1989 98 : 73 9.
5. Sarabu MR, McClung JA, Fass A, Reed GE. Early postoperative spasm in left internal mammary artery bypass grafts. Ann. Thorac. Surg. 1987 44 : 199 200.
6. Blanche C, Chaux A. Spasm in mammary artery grafts. Ann. Thorac. Surg. 1988 45 : 586 (Letter).
7. Von Segesser L, Simonert F, Meier B, Finci L, Faidutti B. Inadequate flow after internal mammary-coronary artery anastomoses. J. Thorac. Cardiovasc. Surg. 1987 35 : 352 4.
8. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989 80 : 1 9.
9. 2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model. J. Cardiovasc. Pharmacol. 2000 35 : 294 301.
10. Shimokawa H, Tomoike H, Nabeyama S et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science 1983 221 : 560 2.
11. Hesistad DD, Armstrong ML, Marcus ML et al. Augmented response to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ. Res. 1984 54 : 711 18.
12. Golino P, Piscione F, Willeron JT et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N. Engl. J. Med. 1991 324 : 641 8.
13. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N. Engl. J. Med. 1991 324 : 648 54.
14. 2A receptor and its antagonists in the cardiovascular system. Pharmacol. Ther. 2004 104 : 59 81.
15. Hoyer D, Clarke DE, Fozard JR et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 1994 46 : 157 203.
16. Nishihira K, Yamashita A, Tanaka N et al. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery. J. Thromb. Haemost. 2006 4 : 247 55.
17. Vikenes K, Farstad M, Nordrehaug JE. Serotonin is associated with coronary artery disease and cardiac events. Circulation 1999 100 : 483 9.
18. Hara K, Hirowatari Y, Yoshika M, Komiyama Y, Tsuka Y, Takahashi H. The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease. J. Lab. Clin. Med. 2004 144 : 31 7.
19. 2 and serotonin are possible mediators. Circulation 1989 79 : 154 66.
20. van den Berg EK, Schmitz JM, Benedict CR et al. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 1989 79 : 116 24.
21. Golino P, Piscione F, Benedict CR et al. Local effect of serotonin released during coronary angioplasty. N. Engl. J. Med. 1994 330 : 523 8.
22. Stojnic N, Bukarica LG, Peric M, Lesic A, Lipkovski JM, Heinle H. Analysis of vasoreactivity of isolated human radial artery. J. Pharmacol. Sci. 2006 100 : 34 40.
23. Ark M, Ozveren E, Yazici G et al. Effects of HA-1077 and Y-27632, two rho-kinase inhibitors, in the human umbilical artery. Cell Biochem. Biophys. 2004 41 : 331 42.
24. Wackenfors A, Jarvius M, Ingemansson R, Edvinsson L, Malmsjo M. Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. J. Cardiovasc. Pharmacol. 2005 45 : 476 84.
25. Nilsson T, Longmore J, Shaw D et al. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur. J. Pharmacol. 1999 372 : 49 56.
26. 2 receptor subtypes in human coronary arteries. Cardiovasc. Res. 1999 41 : 267 74.
27. Chester AH, Martin GR, Bodelsson M et al. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc. Res. 1990 24 : 932 7.
28. 2 receptor activation. Eur. J. Pharmacol. 1989 16 : 91 4.
29. Gul H, Yildiz O, Simsek A et al. Pharmacologic characterization of contractile serotonergic receptors in human isolated mesenteric artery. J. Cardiovasc. Pharmacol. 2003 41 : 307 15.
30. Verheggen R, Meier A, Werner I et al. Functional 5-HT receptors in human occipital artery. Naunyn Schmiedebergs Arch. Pharmacol. 2004 369 : 391 401.
31. Hara H, Osakabe M, Kitajima A, Tamao Y, Kikumoto R. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb. Haemost. 1991 65 : 415 20.
32. 3H]ketanserin for serotonin-2 receptor in the rabbit platelet. J. Pharmacobiodyn. 1991 14 : 461 6.
33. Maruyama K, Kinami J, Sugita Y et al. MCI-9042: High affinity for serotonergic receptors as assessed by radioligand binding assay. J. Pharmacobiodyn. 1991 14 : 177 81.
34. Nishio H, Inoue A, Nakata Y. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes. Arch. Int. Pharmacodyn. Ther. 1996 331 : 189 202.
35. 1B receptors causes hypothermia in the guinea pig. Eur. J. Pharmacol. 1997 331 : 169 74.
36. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann. Thorac. Surg. 1995 59 : 676 83.